{"schema_version":"secwatch.filing_event.v1","accession":"0001333493-23-000006","form_type":"8-K","ticker":"EHTH","cik":"0001333493","company_name":"eHealth, Inc.","filed_at":"2023-01-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.517786+00:00","generated_at":"2026-06-20T10:37:48.683733+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"eHealth Q4 prelim rev $190-200M, FY rev $395-405M; narrower adjusted EBITDA loss vs guidance","bullets":["Revenue for FY2022 expected $395-405M, above prior guidance of $375-395M.","GAAP net loss for FY2022 expected $88-93M, improved from $92-115M guidance.","Adjusted EBITDA for FY2022 expected loss of $40-50M, better than $45-73M guidance.","Total cash outflow for FY2022 (excl. term loan) expected $44M vs guidance of $90-110M.","Medicare Advantage Approved Applications fell 24% YoY to 302,949; cost savings exceeded $110M."],"urls":{"canonical":"https://secwatch.observer/filing/0001333493-23-000006","json":"https://secwatch.observer/filing/0001333493-23-000006.json","markdown":"https://secwatch.observer/filing/0001333493-23-000006.md","text":"https://secwatch.observer/filing/0001333493-23-000006.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1333493/000133349323000006/0001333493-23-000006-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1333493/000133349323000006/ehth-20230124.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T10:37:48.683733+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f1577f96f0114ef50a2314f96c66fc0eeea834e6","claim":"eHealth, Inc. reported the fourth quarter and fiscal year ended December 31, 2022 results: revenue Revenue for the fourth quarter of 2022 is expected to be in the range of $190 to $200 million. Revenue for the year ende, net income GAAP net income for the fourth quarter of 2022 is expected to be in the range of $16 to $21 million. GAAP net loss for t.","evidence_excerpt":"• Revenue for the fourth quarter of 2022 is expected to be in the range of $190 to $200 million. Revenue for the year ended December 31, 2022 is expected to be in the range of $395 to $405 million as compared to the company’s guidance of $375 to $395 million. • GAAP net income for the fourth quarter of 2022 is expected to be in the range of $16 to $21 million. GAAP net loss for the year ended December 31, 2022 is expected to be in the range of $93 to $88 million as compared to the company’s guidance of $115 to $92 million.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1333493/000133349323000006/0001333493-23-000006-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter and fiscal year ended December 31, 2022"},{"label":"Revenue","value":"Revenue for the fourth quarter of 2022 is expected to be in the range of $190 to $200 million. Revenue for the year ende"},{"label":"Net income","value":"GAAP net income for the fourth quarter of 2022 is expected to be in the range of $16 to $21 million. GAAP net loss for t"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}